Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 226-218-8 | CAS number: 5329-14-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
LD50 oral: 2065 mg/kg in rat.
LD50 dermal: >2000 mg/kg in rat
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- January 1969
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Although the study is pre-dating OECD method and GLP, the description is solid justifying sufficient validity of results reported and follows scientific principles at the time of study (1969).
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- yes
- Remarks:
- only females used, no negative control
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- 12 hours prior to application rats were not fed. During observation period of 7 days rats received Standard Altromin R feed (supplied by Altromin GmbH, Lage/Lippe, Germany) and tab water.
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Remarks:
- 10% aqueous solution
- Details on oral exposure:
- single application by gavage of 10% aqueous solution.
- Doses:
- 630, 1000, 1600, 2500 and 4000 mg/kg bw
- No. of animals per sex per dose:
- 10 females per dose
- Control animals:
- no
- Statistics:
- LD50 was derived using the Kärber method.
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 2 065 mg/kg bw
- Based on:
- test mat.
- Mortality:
- at 630 mg/kg bw: no mortality (0/10)
at 1000 mg/kg bw.: 0/10
at 1600 mg/kg bw.: 3/10
at 2500 mg/kg bw.: 8/10
at 4000 mg/kg bw.: 10/10 - Clinical signs:
- other: all death occured within 30 minutes to 24 hours following application. Clinical signs were imbalance, paralysis of rear extremities and death in lateral position. Ras dosed 2500 mg/kg bw showed slight shivering convulse.
- Gross pathology:
- Upon autopsy clear signs of corrosivity to mucosa of gastro-intestinal tract were seen in animals that died during the study.
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The LD50 (oral, rat, female) was determined being 2065 mg/kg bw.
- Executive summary:
In this study 10 female Wistar rats per dose group were orally exposed (by gavage) to 630, 1000, 1600, 2500 and 4000 mg/kg bw. The substance was applied as 10% aqueous solution and the observation period was 7 days. Death occured within 24 hours in the dose groups 1600 (3/10), 2500 (8/10) and 4000 (10/10) mg/kg bw. and the LD50 was set to 2065 mg/kg bw. Although the study is pre-dating OECD method and GLP, the description is solid justifying sufficient validity of results reported and follows scientific principles at the time of study (1969).
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 065 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2010
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source:Charles River Deutschland GmbH, D-97633 Sulzfeld.
- Age at study initiation:Approximately 8 weeks (males) and 12 weeks (females) at the time of administration.
- Weight at study initiation: See Table 2.
- Health conditions: A health inspection was performed prior to the commencement of treatment to ensure, that the animals were in a good state of health. Special attention was paid to the skin to be treated, which was intact and free from any abnormality.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): Mean of 22°C +/- 3 °C (continuous control and recording).
- Humidity (%): Mean of 30 – 70 % (continuous control and recording).
- Air changes (per hr): 12 per hour.
- Photoperiod (hrs dark / hrs light):Artificial light from 6 a.m. to 6 p.m.
- Cages:Single caging in Makrolon cages type III (37.5 cm x 21.5 cm bottom area, 18 cm height). Wire mesh lids. Sanitation of cages once a week.
- Bedding material:Aspen wood chips, Fa. ABEDD Dominik Mayr KEG, A-8580 Köflach, autoclaved. Random samples of the bedding material are analysed for contaminants by the supplier. Changes 1 / week.
- Environmental enrichment:Nibbling wood bricks (10 cm x 2 cm x 2 cm) and nesting material, both from the same material and source as the bedding material, were offered to the animals once a week.
- Feed: Ssniff R/M-H maintenance diet for rats and mice (item V1534-300) ad libitum, supplied by Ssniff Spezialdiäten GmbH, 59494 Soest, Germany. Analysis of the feed for ingredients and contaminants is performed randomly by Ssniff.
- Water:Tap water, from an automatic watering system, ad libitum.
Random samples of the water are analysed by the "AGES",
A-1226 Vienna, to check, if the water fulfils the requirements for drinking water for humans.
-Identification:Labelling with felt-tipped pen on the tail and on the cage.
-Acclimatisation: At least 7 days. - Type of coverage:
- semiocclusive
- Vehicle:
- water
- Details on dermal exposure:
- "SULPHAMIDIC ACID" was administered once topically on an area of approximately
6.5 cm x 8 cm on the dorsal thoracic region of 5 male and 5 female Sprague Dawley rats.
The dose was 2000 mg per kg body weight.
A cellulose patch with the calculated amount of the test substance on the surface and soaked with deionised water to get optimal contact with the skin, was applied to the test site and held in place by fixing marginally with non irritating tape.
The test site was covered by a semi-occlusive dressing.
The duration of the exposure was 24 hours. - Duration of exposure:
- The duration of exposure was 24 hours.
- Doses:
- 2000 mg/kg
- No. of animals per sex per dose:
- 5 per sex per dose
- Control animals:
- not required
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: yes
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight,organ weights, histopathology - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- All animals survived until the scheduled termination of the study.
- Clinical signs:
- other: See Table 3. General findings: All animals did not show any clinical signs during the entire observation period. Observations of skin condition: Exposed skin was not found to be altered by the test substance.
- Gross pathology:
- See Table 4.
No abnormal findings were made in the animals at terminal necropsy. - Other findings:
- Sex differences:
No noteworthy sex difference in the response to the test substance was derived from clinical observations or post-mortem findings. - Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- No local or systemic test substance related effects were noted from clinical observations or post-mortem examination at a dose of 2000 mg test substance per kg body weight. Therefore, the LD50 (dermal, rat) is >2000 mg/kg bw.
- Executive summary:
No local or systemic test substance related effects were noted in this limit test for acute dermal toxicity, applying 2000 mg/kg bw semiocclusively. Clinical observations and post-mortem examination did not reveal any test substance related effects. Therefore, the LD50 (dermal, rat) is >2000 mg/kg bw.
Reference
Table1: Synopsis of the results
Sex |
Animal |
Dose |
Number of animals |
||
|
Nos. |
(mg / kg b.w.) |
exposed |
affected |
deceased |
m |
321-325 |
2000 |
5 |
0 |
0 |
f |
326-330 |
2000 |
5 |
0 |
0 |
Table2: Body weights and body weight gain.
Individual data, mean and standard deviation SD.
Dose |
Animal |
Body weight (g) |
Body weight gain (g) |
||||
Sex |
No. |
before |
7 days |
14 days |
death |
0-7 days |
7-14 days |
|
321 |
293 |
340 |
388 |
- |
47 |
48 |
2000 mg/kg |
322 |
278 |
335 |
378 |
- |
57 |
43 |
male |
323 |
289 |
312 |
347 |
- |
23 |
35 |
|
324 |
289 |
328 |
378 |
- |
39 |
50 |
|
325 |
271 |
296 |
331 |
- |
25 |
35 |
|
mean |
284.0 |
322.2 |
364.4 |
- |
38.2 |
42.2 |
|
SD |
9.2 |
18.1 |
24.2 |
- |
14.5 |
7.0 |
|
326 |
242 |
254 |
268 |
- |
12 |
14 |
2000 mg/kg |
327 |
253 |
253 |
261 |
- |
0 |
8 |
female |
328 |
229 |
230 |
234 |
- |
1 |
4 |
|
329 |
234 |
241 |
252 |
- |
7 |
11 |
|
330 |
233 |
235 |
246 |
- |
2 |
11 |
|
mean |
238.2 |
242.6 |
252.2 |
- |
4.4 |
9.6 |
|
SD |
9.5 |
10.7 |
13.2 |
- |
5.0 |
3.8 |
Table3: Observations in life.
Findings |
Dose |
No. of the affected animals |
Observation time |
Maximum grade of severity |
no clinical signs |
2000 m |
321, 322, 323, 324, 325 |
0 h / 14 d |
- |
|
2000 f |
326, 327, 328, 329, 330 |
0 h / 14 d |
- |
Table4: Necropsy findings.
SYSTEM |
Dose |
No. of affected |
no abnormal findings |
2000, m |
321, 322, 323, 324, 325 |
|
2000, f |
326, 327, 328, 329, 330 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Additional information
Acute toxicity by oral exposure
Sulphamidic acid has been assessed for acute oral toxicity by several studies.
Ambrose et al. investigated the acute toxicity in 1942 by applying up to 1.6 g/kg bw of sulphamidic acid to rats but also equimolar amounts of ammonium sulphamate. However, at the highest dose tested (1.6 g/kg bw sulphamidic acid) the LD50 value was not reached as only 2 out of 8 animals at the high dose group were found dead after 12 – 20 hours of exposure (by gavage). When equimolar amounts of ammonium sulphamate (approx. 1.88 g/kg bw) were applied in the same test design, no mortality was observed. Thus, mortality observed with sulphamidic acid at 1.6 g/kg bw may be mainly attributable to the very low pH of the test substance.
Marhold et al. published in a check Journal in 1972 results for acute oral toxicity to rats for sulphamidic acid to be 3160 mg/kg bw. As only an abstract of the publication is available in English, no further details are known and the reliability of this study was therefore considered not assignable (Klimisch 4). However, this result is widely used in the public domain for sulphamidic acid.
In a Russian publication from 1987 (no translation available but only secondary literature) an LD50 of 1450 mg/kg bw to rats is reported according to secondary sources. However, some secondary sources do indicate that in this publication rather behavioural changes such as altered sleep time (including change in righting reflex), excitement and rigidity (including catalepsy) of animals was observed and not necessarily mortality and thus this result maybe should be considered as an EC50 value rather than a LD50-value. Hence, due to lack of study details and clarity about the effects observed/reported this study is considered not assignable (Klimisch 4) and should not be given too much weight if any.
The most reliable study available on acute oral toxicity (considered reliable with restrictions, Klimisch 2) has been performed by Hoechst toxicology department in 1969. The study report is available and of good quality and although only female rats were used in this study and no negative control was used, the study design was in principle in line with OECD guidelines as developed some time later. Five dose groups (630, 1000, 1600, 2500, 4000 mg/kg bw) were tested and at 1600 mg/kg bw 3 out of 10 animals were found dead (at lower doses no mortality was observed). Whereas at 2500 mg/kg 8/10 animals were found dead at 4000 mg/kg all animals died. Mortality occurred within 24 hours after dosing (by gavage) in all cases. The LD50 in this study was set to 2065 mg/kg bw and observations made are well supported by the data published by Ambrose et al. (see above).
In summary, the LD50 value of 2065 mg/kg bw appears reliable and supported by the finding published by Ambrose et al. The other two publications (EC50 of 1450 mg/kg bw and LC50 of 3160 mg/kg bw) are of limited validity and cannot be assessed in detail.
Thus, in a weight of evidence approach the LD50 value for acute oral toxicity to rats taken forward for hazard and risk assessment is 2065 mg/kg bw.
Acute toxicity by inhalation exposure
No studies on acute toxicity of sulphamidic acid by inhalation were identified and considering the rather course particle size (the particle size was determined being 505.28 µm (median diameter) with a 10% percentile of 189.74 µm - No particles were found being below 5 µm and only 0.5 % of particles were smaller than 10 µm) and the very low vapour pressure of 0.8 Pa at 20 °C and 2.5 Pa at 100 °C, inhalation exposure to sulphamidic acid is not considered relevant.
Acute toxicity by dermal exposure
The acute dermal toxicity of sulphamidic acid was investigated by an OECD402 limit test according to GLP where a dose of 2000 mg/kg bw was applied to rat skin (males and females, semiocclusive). No mortality occurred in this study and also no treatment related effects to the animals were observed.
Acute toxicity by other routes of exposure
Ambrose et al. has investigated in 1942 also the toxicity of sulphamidic acid (pH of 0.82) and its ammonium salt (pH 4.82) by intraperitoneal exposure (compare to oral exposure above). Whereas the LD50 found for sulphamidic acid was lower than 100 mg/kg bw (at 100 mg/kg bw as lowest dose tested 4 out of 5 animals died) , the LD50 for ammonium sulphamate was found to be in the range of 400 – 940 mg/kg bw. These finding do support the assumption that the strong acidity of sulphamic acid is the dominant effect once the substance is absorbed and also show that the absorption rate of sulphamidic acid in the gastrointestinal tract in presumably lower than 10% when comparing these findings with those found by the same author by applying the substances through oral exposure.
The following information is taken into account for hazard and risk assessment:
LD50 oral: 2065 mg/kg bw in rat.
LD50 dermal: >2000 mg/kg bw in rat
Value used for CSA:
Acute oral toxicity: (LD50: 2065 mg/kg bw)
Acute dermal toxicity: No adverse effect observed (LD50: >2000 mg/kg bw)
Acute inhalation toxicity: No study available
Justification for selection of acute toxicity – oral endpoint
most reliable study in this weight of evidence approach
Justification for classification or non-classification
Based on the test results, no classification for acute toxicity is proposed for acute oral or dermal toxicity of this substance according to Regulation (EC) NO 1272/2008 of the European Parliament and of the Council of 16 December 2008. Data on acute inhalation toxicity is not required as the substance is a crystalline and course material with negligible vapour pressure. Also, classification for aspiration hazards according to CLP (Regulation EC No 1272/2008) is not required as the substance is solid and not a hydrocarbon. The available acute studies do not indicate any specific target organ toxicity effects and thus classification for STOT Single Exposure according to CLP is not required.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.